Year |
Citation |
Score |
2008 |
Spence EJ, Nornberg MD, Bayliss RA, Kendrick RD, Forest CB. Fluctuation-driven magnetic fields in the Madison Dynamo Experiment Physics of Plasmas. 15. DOI: 10.1063/1.2890753 |
0.612 |
|
2008 |
Reuter K, Jenko F, Forest CB, Bayliss RA. A parallel implementation of an MHD code for the simulation of mechanically driven, turbulent dynamos in spherical geometry Computer Physics Communications. 179: 245-249. DOI: 10.1016/J.Cpc.2008.02.011 |
0.565 |
|
2007 |
Bayliss RA, Forest CB, Nornberg MD, Spence EJ, Terry PW. Numerical simulations of current generation and dynamo excitation in a mechanically forced turbulent flow. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics. 75: 026303. PMID 17358418 DOI: 10.1103/Physreve.75.026303 |
0.608 |
|
2002 |
Forest CB, Bayliss RA, Kendrick RD, Nornberg MD, O'Connell R, Spence EJ. Hydrodynamic and numerical modeling of a spherical homogeneous dynamo experiment Magnitnaya Gidrodinamika. 38: 107-121. |
0.577 |
|
Low-probability matches (unlikely to be authored by this person) |
2018 |
Mittauer K, Paliwal B, Hill P, Bayouth JE, Geurts MW, Baschnagel AM, Bradley KA, Harari PM, Rosenberg S, Brower JV, Wojcieszynski AP, Hullett C, Bayliss RA, Labby ZE, Bassetti MF. A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic Malignancies. Cureus. 10: e2422. PMID 29872602 DOI: 10.7759/Cureus.2422 |
0.149 |
|
2023 |
Dawber RS, Gimenez D, Batchelor M, Miles JA, Wright MH, Bayliss R, Wilson AJ. Inhibition of Aurora-A/N-Myc protein-protein interaction using peptidomimetics: Understanding the role of peptide cyclization. Chembiochem : a European Journal of Chemical Biology. e202300649. PMID 37907395 DOI: 10.1002/cbic.202300649 |
0.125 |
|
2007 |
Sovinec CR, Barnes DC, Bayliss RA, Brennan DP, Held ED, Kruger SE, Pankin AY, Schnackand DD. Two-fluid studies of edge relaxation events in tokamaks Journal of Physics: Conference Series. 78. DOI: 10.1088/1742-6596/78/1/012070 |
0.124 |
|
2024 |
Burgess SG, Paul NR, Richards MW, Ault JR, Askenatzis L, Claydon SG, Corbyn R, Machesky LM, Bayliss R. A nanobody inhibitor of Fascin-1 actin-bundling activity and filopodia formation. Open Biology. 14: 230376. PMID 38503329 DOI: 10.1098/rsob.230376 |
0.12 |
|
2024 |
Kim M, Ju HM, Song JY, Sampson J, Bayliss R, Choi J. HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors. Translational Lung Cancer Research. 13: 321-333. PMID 38496685 DOI: 10.21037/tlcr-23-804 |
0.12 |
|
2001 |
Bayliss R. Balzac and cretinism. Journal of the Royal College of Physicians of London. 34: 398-400. PMID 11005083 |
0.12 |
|
2015 |
Winter A, Schmid R, Bayliss R. Structural Insights into Separase Architecture and Substrate Recognition through Computational Modelling of Caspase-Like and Death Domains. Plos Computational Biology. 11: e1004548. PMID 26513470 DOI: 10.1371/journal.pcbi.1004548 |
0.114 |
|
2017 |
Wojcieszynski AP, Hill PM, Rosenberg SA, Hullett CR, Labby ZE, Paliwal B, Geurts MW, Bayliss RA, Bayouth JE, Harari PM, Bassetti MF, Baschnagel AM. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans. Technology in Cancer Research & Treatment. 1533034617691407. PMID 28168936 DOI: 10.1177/1533034617691407 |
0.114 |
|
2011 |
Bayliss RA, Sovinec CR, Redd AJ. Zero-β modeling of coaxial helicity injection in the HIT-II spherical torus Physics of Plasmas. 18. DOI: 10.1063/1.3626563 |
0.11 |
|
2018 |
Yeoh S, Bayliss R. New tools for evaluating protein tyrosine sulfation and carbohydrate sulfation. The Biochemical Journal. 475: 3035-3037. PMID 30291171 DOI: 10.1042/BCJ20180480 |
0.103 |
|
2023 |
Morris BA, Holmes EE, Anger NJ, Cooley G, Schuster JM, Hurst N, Baschnagel AM, Bassetti MF, Blitzer GC, Chappell RJ, Bayliss RA, Morris ZS, Ritter MA, Floberg JM. Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 Trial. International Journal of Radiation Oncology, Biology, Physics. PMID 37179035 DOI: 10.1016/j.ijrobp.2023.05.004 |
0.1 |
|
2016 |
Bachmann G, Richards MW, Winter A, Beuron F, Morris E, Bayliss R. A closed conformation of the Caenorhabditis elegans separase-securin complex. Open Biology. 6. PMID 27249343 DOI: 10.1098/rsob.160032 |
0.09 |
|
2023 |
Floberg JM, Wells SA, Ojala D, Bayliss RA, Hill PM, Morris BA, Morris ZS, Ritter M, Cho SY. Using F-DCFPyL Prostate-Specific Membrane Antigen-Directed Positron Emission Tomography/Magnetic Resonance Imaging to Define Intraprostatic Boosts for Prostate Stereotactic Body Radiation Therapy. Advances in Radiation Oncology. 8: 101241. PMID 37250282 DOI: 10.1016/j.adro.2023.101241 |
0.086 |
|
2022 |
Tomlinson LJ, Batchelor M, Sarsby J, Byrne DP, Brownridge PJ, Bayliss R, Eyers PA, Eyers CE. Exploring the Conformational Landscape and Stability of Aurora A Using Ion-Mobility Mass Spectrometry and Molecular Modeling. Journal of the American Society For Mass Spectrometry. 33: 420-435. PMID 35099954 DOI: 10.1021/jasms.1c00271 |
0.084 |
|
2022 |
Batchelor M, Dawber RS, Wilson AJ, Bayliss R. α-Helix stabilization by co-operative side chain charge-reinforced interactions to phosphoserine in a basic kinase-substrate motif. The Biochemical Journal. 479: 687-700. PMID 35212726 DOI: 10.1042/BCJ20210812 |
0.08 |
|
2015 |
Richards MW, O'Regan L, Roth D, Montgomery JM, Straube A, Fry AM, Bayliss R. Microtubule association of EML proteins and the EML4-ALK variant 3 oncoprotein require an N-terminal trimerization domain. The Biochemical Journal. 467: 529-36. PMID 25740311 DOI: 10.1042/Bj20150039 |
0.078 |
|
2023 |
Elshatlawy M, Sampson J, Clarke K, Bayliss R. EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries. Molecular Oncology. 17: 950-963. PMID 37149843 DOI: 10.1002/1878-0261.13446 |
0.076 |
|
2014 |
Richards MW, Law EW, Rennalls LP, Busacca S, O'Regan L, Fry AM, Fennell DA, Bayliss R. Crystal structure of EML1 reveals the basis for Hsp90 dependence of oncogenic EML4-ALK by disruption of an atypical β-propeller domain. Proceedings of the National Academy of Sciences of the United States of America. 111: 5195-200. PMID 24706829 DOI: 10.1073/pnas.1322892111 |
0.076 |
|
2019 |
Zhang R, McIntyre PJ, Collins PM, Foley DJ, Arter C, von Delft F, Bayliss R, Warriner S, Nelson A. Construction of a Shape-Diverse Fragment Set: Design, Synthesis and Screen against Aurora-A Kinase. Chemistry (Weinheim An Der Bergstrasse, Germany). PMID 31026091 DOI: 10.2210/Pdb6R49/Pdb |
0.076 |
|
2010 |
Oberoi J, Richards MW, Crumpler S, Brown N, Blagg J, Bayliss R. Structural basis of poly(ADP-ribose) recognition by the multizinc binding domain of checkpoint with forkhead-associated and RING Domains (CHFR). The Journal of Biological Chemistry. 285: 39348-58. PMID 20880844 DOI: 10.1074/Jbc.M110.159855 |
0.072 |
|
1984 |
Bayliss R, Clarke C, Oakley C, Somerville W, Whitfield AG. The teeth and infective endocarditis. British Heart Journal. 50: 506-12. PMID 6360190 DOI: 10.1136/hrt.50.6.506 |
0.072 |
|
2016 |
Concilio MG, Fielding AJ, Bayliss R, Burgess SG. Density functional theory studies of MTSL nitroxide side chain conformations attached to an activation loop. Theoretical Chemistry Accounts. 135: 97. PMID 27069413 DOI: 10.1007/s00214-016-1859-z |
0.071 |
|
2013 |
Dodson CA, Yeoh S, Haq T, Bayliss R. A kinetic test characterizes kinase intramolecular and intermolecular autophosphorylation mechanisms. Science Signaling. 6: ra54. PMID 23821772 DOI: 10.1126/scisignal.2003910 |
0.07 |
|
2020 |
O'Regan L, Barone G, Adib R, Woo CG, Jeong HJ, Richardson EL, Richards MW, Muller PAJ, Collis SJ, Fennell DA, Choi J, Bayliss R, Fry AM. EML4-ALK V3 oncogenic fusion proteins promote microtubule stabilization and accelerated migration through NEK9 and NEK7. Journal of Cell Science. PMID 32184261 DOI: 10.1242/jcs.241505 |
0.07 |
|
2021 |
Roeschert I, Poon E, Henssen AG, Garcia HD, Gatti M, Giansanti C, Jamin Y, Ade CP, Gallant P, Schülein-Völk C, Beli P, Richards M, Rosenfeldt M, Altmeyer M, Anderson J, ... ... Bayliss R, et al. Combined inhibition of Aurora-A and ATR kinase results in regression of -amplified neuroblastoma. Nature Cancer. 2: 312-326. PMID 33768209 DOI: 10.1038/s43018-020-00171-8 |
0.068 |
|
2012 |
Dodson CA, Bayliss R. Activation of Aurora-A kinase by protein partner binding and phosphorylation are independent and synergistic Journal of Biological Chemistry. 287: 1150-1157. PMID 22094468 DOI: 10.1074/jbc.M111.312090 |
0.067 |
|
2022 |
Papageorgiou S, Pashley SL, O'Regan L, Khan S, Bayliss R, Fry AM. Alternative Treatment Options to ALK Inhibitor Monotherapy for EML4-ALK-Driven Lung Cancer. Cancers. 14. PMID 35884511 DOI: 10.3390/cancers14143452 |
0.065 |
|
2015 |
Flayhan A, Bergé C, Baïlo N, Doublet P, Bayliss R, Terradot L. The structure of Legionella pneumophila LegK4 type four secretion system (T4SS) effector reveals a novel dimeric eukaryotic-like kinase. Scientific Reports. 5: 14602. PMID 26419332 DOI: 10.1038/Srep14602 |
0.065 |
|
2019 |
Bayliss R. A Less Accurate History of Babinski. Journal of the Royal College of Physicians of London. 30: 189-190. PMID 30668025 |
0.065 |
|
2013 |
Bayliss R, Fry A, Haq T, Yeoh S. On the molecular mechanisms of mitotic kinase activation. Open Biology. 2: 120136. PMID 23226601 DOI: 10.1098/rsob.120136 |
0.064 |
|
2023 |
Preston HE, Bayliss R, Temperton N, Neto MM, Brewer J, Parker AL. Capture and inactivation of viral particles from bioaerosols by electrostatic precipitation. Iscience. 26: 107567. PMID 37664619 DOI: 10.1016/j.isci.2023.107567 |
0.064 |
|
2014 |
Bojar D, Martinez J, Santiago J, Rybin V, Bayliss R, Hothorn M. Crystal structures of the phosphorylated BRI1 kinase domain and implications for brassinosteroid signal initiation. The Plant Journal : For Cell and Molecular Biology. 78: 31-43. PMID 24461462 DOI: 10.1111/Tpj.12445 |
0.063 |
|
1998 |
Williams DJ, Bayliss R, Hinchliffe R. Surgical technique. Intravenous access: obtaining large-bore access in the shocked patient. Annals of the Royal College of Surgeons of England. 79: 466. PMID 9422881 |
0.063 |
|
1979 |
Bayliss RA. Mr Punch and medicine in the 1840s. The Practitioner. 222: 140-3. PMID 368756 |
0.062 |
|
2015 |
Burgess SG, Peset I, Joseph N, Cavazza T, Vernos I, Pfuhl M, Gergely F, Bayliss R. Aurora-A-Dependent Control of TACC3 Influences the Rate of Mitotic Spindle Assembly. Plos Genetics. 11: e1005345. PMID 26134678 DOI: 10.1371/journal.pgen.1005345 |
0.062 |
|
2007 |
Hare S, Fischer W, Williams R, Terradot L, Bayliss R, Haas R, Waksman G. Identification, structure and mode of action of a new regulator of the Helicobacter pylori HP0525 ATPase. The Embo Journal. 26: 4926-34. PMID 17972918 DOI: 10.1038/Sj.Emboj.7601904 |
0.062 |
|
2019 |
Tsuchiya Y, Byrne DP, Burgess SG, Bormann J, Baković J, Huang Y, Zhyvoloup A, Yu BYK, Peak-Chew S, Tran T, Bellany F, Tabor AB, Chan AE, Guruprasad L, Garifulin O, ... ... Bayliss R, et al. Covalent Aurora A regulation by the metabolic integrator coenzyme A. Redox Biology. 28: 101318. PMID 31546169 DOI: 10.1016/j.redox.2019.101318 |
0.061 |
|
2017 |
McIntyre PJ, Collins PM, Vrzal L, Birchall K, Arnold LH, Mpamhanga C, Coombs PJ, Burgess SG, Richards MW, Winter A, Veverka V, von Delft F, Merritt A, Bayliss R. Characterization of three druggable hotspots in the Aurora-A/TPX2 interaction using biochemical, biophysical and fragment-based approaches. Acs Chemical Biology. PMID 29045126 DOI: 10.1021/acschembio.7b00537 |
0.061 |
|
2015 |
Joshi A, Newbatt Y, McAndrew PC, Stubbs M, Burke R, Richards MW, Bhatia C, Caldwell JJ, McHardy T, Collins I, Bayliss R. Molecular mechanisms of human IRE1 activation through dimerization and ligand binding. Oncotarget. 6: 13019-35. PMID 25968568 DOI: 10.18632/Oncotarget.3864 |
0.061 |
|
2016 |
Burgess SG, Grazia Concilio M, Bayliss R, Fielding AJ. Detection of Ligand-induced Conformational Changes in the Activation Loop of Aurora-A Kinase by PELDOR Spectroscopy. Chemistryopen. 5: 531-534. PMID 28032021 DOI: 10.1002/open.201600101 |
0.06 |
|
2017 |
Bayliss R, Burgess SG, McIntyre PJ. Switching Aurora-A kinase on and off at an allosteric site. The Febs Journal. PMID 28342286 DOI: 10.1111/febs.14069 |
0.059 |
|
2016 |
Burgess SG, Oleksy A, Cavazza T, Richards MW, Vernos I, Matthews D, Bayliss R. Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain. Open Biology. 6. PMID 27411893 DOI: 10.1098/rsob.160089 |
0.059 |
|
2019 |
Adib R, Montgomery JM, Atherton J, O'Regan L, Richards MW, Straatman KR, Roth D, Straube A, Bayliss R, Moores CA, Fry AM. Mitotic phosphorylation by NEK6 and NEK7 reduces the microtubule affinity of EML4 to promote chromosome congression. Science Signaling. 12. PMID 31409757 DOI: 10.1126/Scisignal.Aaw2939 |
0.059 |
|
2016 |
Richards MW, Burgess SG, Poon E, Carstensen A, Eilers M, Chesler L, Bayliss R. Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors. Proceedings of the National Academy of Sciences of the United States of America. PMID 27837025 DOI: 10.1073/Pnas.1610626113 |
0.059 |
|
2010 |
Dodson CA, Kosmopoulou M, Richards MW, Atrash B, Bavetsias V, Blagg J, Bayliss R. Crystal structure of an Aurora-A mutant that mimics Aurora-B bound to MLN8054: insights into selectivity and drug design. The Biochemical Journal. 427: 19-28. PMID 20067443 DOI: 10.1042/Bj20091530 |
0.058 |
|
2021 |
Sampson J, Richards MW, Choi J, Fry AM, Bayliss R. Phase-separated foci of EML4-ALK facilitate signalling and depend upon an active kinase conformation. Embo Reports. e53693. PMID 34661367 DOI: 10.15252/embr.202153693 |
0.058 |
|
2019 |
Burr AR, Robins HI, Bayliss RA, Howard SP. Pulsed reduced dose rate for re-irradiation of recurrent breast cancer. Practical Radiation Oncology. PMID 31526900 DOI: 10.1016/j.prro.2019.09.004 |
0.057 |
|
2015 |
Rogerson DT, Sachdeva A, Wang K, Haq T, Kazlauskaite A, Hancock SM, Huguenin-Dezot N, Muqit MM, Fry AM, Bayliss R, Chin JW. Efficient genetic encoding of phosphoserine and its nonhydrolyzable analog. Nature Chemical Biology. 11: 496-503. PMID 26030730 DOI: 10.1038/Nchembio.1823 |
0.057 |
|
2006 |
Harris R, Bayliss R, Waksman G, Driscoll PC. Resonance assignments of the complex between TraN and the C-terminal domain of TraO from the conjugative plasmid pKM101. Journal of Biomolecular Nmr. 36: 31. PMID 16601857 DOI: 10.1007/S10858-006-0015-9 |
0.056 |
|
2020 |
Rombi F, Bayliss R, Tuplin A, Yeoh S. The journey of Zika to the developing brain. Molecular Biology Reports. 47: 3097-3115. PMID 32128708 DOI: 10.1007/s11033-020-05349-y |
0.056 |
|
2006 |
Palmieri TL, Enkhbaatar P, Bayliss R, Traber LD, Cox RA, Hawkins HK, Herndon DN, Greenhalgh DG, Traber DL. Continuous nebulized albuterol attenuates acute lung injury in an ovine model of combined burn and smoke inhalation. Critical Care Medicine. 34: 1719-24. PMID 16607229 DOI: 10.1097/01.Ccm.0000217215.82821.C5 |
0.056 |
|
2017 |
Sampson J, O'Regan L, Dyer MJ, Bayliss R, Fry AM. Hsp72 and Nek6 cooperate to cluster amplified centrosomes in cancer cells. Cancer Research. PMID 28720575 DOI: 10.1158/0008-5472.CAN-16-3233 |
0.056 |
|
2017 |
Bayliss R, Burgess SG, Leen E, Richards MW. A moving target: structure and disorder in pursuit of Myc inhibitors. Biochemical Society Transactions. 45: 709-717. PMID 28620032 DOI: 10.1042/BST20160328 |
0.055 |
|
2014 |
Rowan F, Richards M, Widya M, Bayliss R, Blagg J. Diverse functionalization of Aurora-A kinase at specified surface and buried sites by native chemical modification. Plos One. 9: e103935. PMID 25093837 DOI: 10.1371/Journal.Pone.0103935 |
0.054 |
|
2015 |
Burgess SG, Bayliss R, Pfuhl M. Solution NMR assignment of the cryptic sixth TOG domain of mini spindles. Biomolecular Nmr Assignments. 9: 411-3. PMID 25971232 DOI: 10.1007/s12104-015-9620-4 |
0.054 |
|
2018 |
Rostkova E, Burgess SG, Bayliss R, Pfuhl M. Solution NMR assignment of the C-terminal domain of human chTOG. Biomolecular Nmr Assignments. 12: 221-224. PMID 29582386 DOI: 10.1007/s12104-018-9812-9 |
0.054 |
|
2018 |
Burgess SG, Mukherjee M, Sabir S, Joseph N, Gutiérrez-Caballero C, Richards MW, Huguenin-Dezot N, Chin JW, Kennedy EJ, Pfuhl M, Royle SJ, Gergely F, Bayliss R. Mitotic spindle association of TACC3 requires Aurora-A-dependent stabilization of a cryptic α-helix. The Embo Journal. PMID 29510984 DOI: 10.15252/Embj.201797902 |
0.054 |
|
2023 |
Piovesana M, Wood AKM, Smith DP, Deery MJ, Bayliss R, Carrera E, Wellner N, Kosik O, Napier JA, Kurup S, Matthes MC. A point mutation in the kinase domain of CRK10 leads to xylem vessel collapse and activation of defense responses in Arabidopsis. Journal of Experimental Botany. PMID 36869735 DOI: 10.1093/jxb/erad080 |
0.053 |
|
2010 |
Whelligan DK, Solanki S, Taylor D, Thomson DW, Cheung KM, Boxall K, Mas-Droux C, Barillari C, Burns S, Grummitt CG, Collins I, van Montfort RL, Aherne GW, Bayliss R, Hoelder S. Aminopyrazine inhibitors binding to an unusual inactive conformation of the mitotic kinase Nek2: SAR and structural characterization. Journal of Medicinal Chemistry. 53: 7682-98. PMID 20936789 DOI: 10.1021/jm1008727 |
0.052 |
|
2002 |
BAKER RA, BAYLISS RA. Alexander Gordon Melville (1819–1901): the Dodo, Raphus cucullatus (L., 1758) and the genesis of a book Archives of Natural History. 29: 109-118. DOI: 10.3366/anh.2002.29.1.109 |
0.051 |
|
2013 |
Bavetsias V, Faisal A, Crumpler S, Brown N, Kosmopoulou M, Joshi A, Atrash B, Pérez-Fuertes Y, Schmitt JA, Boxall KJ, Burke R, Sun C, Avery S, Bush K, Henley A, ... ... Bayliss R, et al. Aurora isoform selectivity: design and synthesis of imidazo[4,5-b]pyridine derivatives as highly selective inhibitors of Aurora-A kinase in cells. Journal of Medicinal Chemistry. 56: 9122-35. PMID 24195668 DOI: 10.1021/Jm401115G |
0.051 |
|
2011 |
Baker RA, Bayliss RA. The Valencia Harbour survey (1895 and 1896) in Ireland, with special reference to the work of Edward Thomas Browne (1866-1937) Archives of Natural History. 38: 65-76. DOI: 10.3366/anh.2011.0005 |
0.051 |
|
2016 |
Rennie YK, McIntyre PJ, Akindele T, Bayliss R, Jamieson AG. A TPX2 proteomimetic has enhanced affinity for Aurora-A due to hydrocarbon stapling of a helix. Acs Chemical Biology. PMID 27775325 DOI: 10.1021/acschembio.6b00727 |
0.05 |
|
2011 |
Zalli D, Bayliss R, Fry AM. The Nek8 protein kinase, mutated in the human cystic kidney disease nephronophthisis, is both activated and degraded during ciliogenesis. Human Molecular Genetics. 21: 1155-71. PMID 22106379 DOI: 10.1093/hmg/ddr544 |
0.05 |
|
2004 |
Baker RA, Bayliss RA. Philip Pearsall Carpenter's "passion for shells" Journal of Conchology. 38: 241-251. |
0.05 |
|
2002 |
Bayliss R, Leung SW, Baker RP, Quimby BB, Corbett AH, Stewart M. Structural basis for the interaction between NTF2 and nucleoporin FxFG repeats. The Embo Journal. 21: 2843-53. PMID 12065398 DOI: 10.1093/Emboj/Cdf305 |
0.05 |
|
2005 |
Terradot L, Bayliss R, Oomen C, Leonard GA, Baron C, Waksman G. Structures of two core subunits of the bacterial type IV secretion system, VirB8 from Brucella suis and ComB10 from Helicobacter pylori. Proceedings of the National Academy of Sciences of the United States of America. 102: 4596-601. PMID 15764702 DOI: 10.1073/Pnas.0408927102 |
0.05 |
|
2020 |
Matheson CJ, Coxon CR, Bayliss R, Boxall K, Carbain B, Fry AM, Hardcastle IR, Harnor SJ, Mas-Droux C, Newell DR, Richards MW, Sivaprakasam M, Turner D, Griffin RJ, Golding BT, et al. 2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase. Rsc Medicinal Chemistry. 11: 707-731. PMID 33479670 DOI: 10.1039/d0md00074d |
0.049 |
|
2003 |
Bayliss R, Sardon T, Vernos I, Conti E. Structural basis of Aurora-A activation by TPX2 at the mitotic spindle Molecular Cell. 12: 851-862. PMID 14580337 DOI: 10.1016/S1097-2765(03)00392-7 |
0.049 |
|
2016 |
Bayliss R, Choi J, Fennell DA, Fry AM, Richards MW. Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs. Cellular and Molecular Life Sciences : Cmls. PMID 26755435 DOI: 10.1007/s00018-015-2117-6 |
0.049 |
|
2022 |
Arter C, Trask L, Ward S, Yeoh S, Bayliss R. Structural features of the protein kinase domain and targeted binding by small molecule inhibitors. The Journal of Biological Chemistry. 102247. PMID 35830914 DOI: 10.1016/j.jbc.2022.102247 |
0.049 |
|
2022 |
Sampson J, Ju HM, Song JY, Fry AM, Bayliss R, Choi J. A Polytherapy Strategy Using Vincristine and ALK Inhibitors to Sensitise EML4-ALK-Positive NSCLC. Cancers. 14. PMID 35159046 DOI: 10.3390/cancers14030779 |
0.049 |
|
2016 |
Khan S, Karmokar A, Howells L, Thomas AL, Bayliss R, Gescher A, Brown K. Targeting cancer stem-like cells using dietary-derived agents - where are we now? Molecular Nutrition & Food Research. PMID 27060283 DOI: 10.1002/mnfr.201500887 |
0.049 |
|
2013 |
Dodson CA, Haq T, Yeoh S, Fry AM, Bayliss R. The structural mechanisms that underpin mitotic kinase activation. Biochemical Society Transactions. 41: 1037-41. PMID 23863175 DOI: 10.1042/BST20130066 |
0.049 |
|
2016 |
Fry AM, O'Regan L, Montgomery J, Adib R, Bayliss R. EML proteins in microtubule regulation and human disease. Biochemical Society Transactions. 44: 1281-1288. PMID 27911710 DOI: 10.1042/BST20160125 |
0.048 |
|
2004 |
Bayliss R, Sardon T, Ebert J, Lindner D, Vernos I, Conti E. Determinants for Aurora-A activation and Aurora-B discrimination by TPX2 Cell Cycle. 3: 404-407. PMID 14752279 DOI: 10.4161/Cc.3.4.777 |
0.048 |
|
2010 |
Richards MW, Leung JW, Roe SM, Li K, Chen J, Bayliss R. A pocket on the surface of the N-terminal BRCT domain of Mcph1 is required to prevent abnormal chromosome condensation. Journal of Molecular Biology. 395: 908-15. PMID 19925808 DOI: 10.1016/J.Jmb.2009.11.029 |
0.048 |
|
2009 |
Westwood I, Cheary DM, Baxter JE, Richards MW, van Montfort RL, Fry AM, Bayliss R. Insights into the conformational variability and regulation of human Nek2 kinase. Journal of Molecular Biology. 386: 476-85. PMID 19124027 DOI: 10.1016/j.jmb.2008.12.033 |
0.047 |
|
2006 |
Hare S, Bayliss R, Baron C, Waksman G. A large domain swap in the VirB11 ATPase of Brucella suis leaves the hexameric assembly intact. Journal of Molecular Biology. 360: 56-66. PMID 16730027 DOI: 10.1016/J.Jmb.2006.04.060 |
0.047 |
|
2022 |
Lucken K, O'Regan L, Choi J, Sampson J, Pashley SL, Bayliss R, Khan S, Fry AM. EML4-ALK Variant 3 Promotes Mitotic Errors and Spindle Assembly Checkpoint Deficiency Leading to Increased Microtubule Poison Sensitivity. Molecular Cancer Research : McR. 20: 854-866. PMID 35656694 DOI: 10.1158/1541-7786.MCR-21-1010 |
0.046 |
|
2009 |
Bibby RA, Tang C, Faisal A, Drosopoulos K, Lubbe S, Houlston R, Bayliss R, Linardopoulos S. A cancer-associated Aurora a mutant is mislocalized and misregulated due to loss of interaction with TPX2 Journal of Biological Chemistry. 284: 33177-33184. PMID 19801554 DOI: 10.1074/jbc.M109.032722 |
0.046 |
|
2015 |
Haq T, Richards MW, Burgess SG, Gallego P, Yeoh S, O'Regan L, Reverter D, Roig J, Fry AM, Bayliss R. Mechanistic basis of Nek7 activation through Nek9 binding and induced dimerization. Nature Communications. 6: 8771. PMID 26522158 DOI: 10.1038/ncomms9771 |
0.045 |
|
2020 |
Byrne M, Nasir N, Basmadjian C, Bhatia C, Cunnison RF, Carr KH, Mas-Droux C, Yeoh S, Cano C, Bayliss R. Nek7 conformational flexibility and inhibitor binding probed through protein engineering of the R-spine. The Biochemical Journal. PMID 32242624 DOI: 10.1042/BCJ20200128 |
0.045 |
|
2020 |
Newton R, Waszkowycz B, Seewooruthun C, Burschowsky D, Richards M, Hitchin S, Begum H, Watson A, French E, Hamilton N, Jones S, Lin LY, Waddell I, Echalier A, Bayliss R, et al. Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RET Kinase. Acs Medicinal Chemistry Letters. 11: 497-505. PMID 32292556 DOI: 10.1021/acsmedchemlett.9b00615 |
0.045 |
|
2017 |
Fry AM, Bayliss R, Roig J. Mitotic Regulation by NEK Kinase Networks. Frontiers in Cell and Developmental Biology. 5: 102. PMID 29250521 DOI: 10.3389/fcell.2017.00102 |
0.045 |
|
2020 |
Ryan EL, Shelford J, Massam-Wu T, Bayliss R, Royle SJ. Defining endogenous TACC3-chTOG-clathrin-GTSE1 interactions at the mitotic spindle using induced relocalization. Journal of Cell Science. PMID 33380489 DOI: 10.1242/jcs.255794 |
0.045 |
|
2021 |
Wolpaw AJ, Bayliss R, Büchel G, Dang CV, Eilers M, Gustafson WC, Hansen GM, Jura N, Knapp S, Lemmon MA, Levens D, Maris JM, Marmorstein R, Metallo SJ, Park JR, et al. Drugging the 'undruggable' MYCN oncogenic transcription factor: Overcoming previous obstacles to impact childhood cancers. Cancer Research. PMID 33509943 DOI: 10.1158/0008-5472.CAN-20-3108 |
0.044 |
|
1980 |
Monk BE, Isaacs AJ, Bayliss R. Giant ovarian dermoid masked by obesity Postgraduate Medical Journal. 56: 748-749. PMID 7220416 DOI: 10.1136/pgmj.56.660.748 |
0.044 |
|
2011 |
Solanki S, Innocenti P, Mas-Droux C, Boxall K, Barillari C, van Montfort RL, Aherne GW, Bayliss R, Hoelder S. Benzimidazole inhibitors induce a DFG-out conformation of never in mitosis gene A-related kinase 2 (Nek2) without binding to the back pocket and reveal a nonlinear structure-activity relationship. Journal of Medicinal Chemistry. 54: 1626-39. PMID 21366329 DOI: 10.1021/Jm1011726 |
0.044 |
|
2015 |
Bayliss R, Haq T, Yeoh S. The Ys and wherefores of protein kinase autoinhibition. Biochimica Et Biophysica Acta. 1854: 1586-94. PMID 25936518 DOI: 10.1016/j.bbapap.2015.04.025 |
0.044 |
|
2022 |
Kakade P, Ojha H, Raimi OG, Shaw A, Waddell AD, Ault JR, Burel S, Brockmann K, Kumar A, Ahangar MS, Krysztofinska EM, Macartney T, Bayliss R, Fitzgerald JC, Muqit MMK. Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cells. Open Biology. 12: 210264. PMID 35042401 DOI: 10.1098/rsob.210264 |
0.043 |
|
2012 |
Fry AM, O'Regan L, Sabir SR, Bayliss R. Cell cycle regulation by the NEK family of protein kinases. Journal of Cell Science. 125: 4423-33. PMID 23132929 DOI: 10.1242/jcs.111195 |
0.043 |
|
2002 |
Bayliss R, Littlewood T, Strawn LA, Wente SR, Stewart M. GLFG and FxFG nucleoporins bind to overlapping sites on importin-beta. The Journal of Biological Chemistry. 277: 50597-606. PMID 12372823 DOI: 10.1074/Jbc.M209037200 |
0.043 |
|
2000 |
Bayliss R, Corbett AH, Stewart M. The molecular mechanism of transport of macromolecules through nuclear pore complexes Traffic. 1: 448-456. PMID 11208130 DOI: 10.1034/J.1600-0854.2000.010602.X |
0.042 |
|
2019 |
Colombano G, Caldwell JJ, Matthews TP, Bhatia C, Joshi A, McHardy T, Mok NY, Newbatt Y, Pickard L, Strover J, Hedayat S, Walton MI, Myers S, Jones AM, Saville H, ... ... Bayliss R, et al. Binding to an unusual inactive kinase conformation by highly selective inhibitors of inositol-requiring enzyme 1α kinase-endoribonuclease. Journal of Medicinal Chemistry. PMID 30779566 DOI: 10.1021/Acs.Jmedchem.8B01721 |
0.042 |
|
2021 |
Teijeira Crespo A, Burnell S, Capitani L, Bayliss R, Moses E, Mason GH, Davies JA, Godkin AJ, Gallimore AM, Parker AL. Pouring petrol on the flames: using oncolytic virotherapies to enhance tumour immunogenicity. Immunology. PMID 33638871 DOI: 10.1111/imm.13323 |
0.042 |
|
2009 |
Richards MW, O'Regan L, Mas-Droux C, Blot JM, Cheung J, Hoelder S, Fry AM, Bayliss R. An autoinhibitory tyrosine motif in the cell-cycle-regulated Nek7 kinase is released through binding of Nek9. Molecular Cell. 36: 560-70. PMID 19941817 DOI: 10.1016/J.Molcel.2009.09.038 |
0.042 |
|
2014 |
Mohindra P, Urban E, Pagan JD, Geye HM, Patel VB, Bayliss RA, Bender ET, Harari PM. Selective omission of level V nodal coverage for patients with oropharyngeal cancer: Clinical validation of intensity-modulated radiotherapy experience and dosimetric significance. Head & Neck. PMID 25445257 DOI: 10.1002/Hed.23924 |
0.041 |
|
2013 |
Hood FE, Williams SJ, Burgess SG, Richards MW, Roth D, Straube A, Pfuhl M, Bayliss R, Royle SJ. Coordination of adjacent domains mediates TACC3-ch-TOG-clathrin assembly and mitotic spindle binding. The Journal of Cell Biology. 202: 463-78. PMID 23918938 DOI: 10.1083/Jcb.201211127 |
0.041 |
|
2018 |
Mukherjee M, Sabir S, O'Regan L, Sampson J, Richards MW, Huguenin-Dezot N, Ault JR, Chin JW, Zhuravleva A, Fry AM, Bayliss R. Mitotic phosphorylation regulates Hsp72 spindle localization by uncoupling ATP binding from substrate release. Science Signaling. 11. PMID 30108182 DOI: 10.1126/Scisignal.Aao2464 |
0.041 |
|
2001 |
Stewart M, Baker RP, Bayliss R, Clayton L, Grant RP, Littlewood T, Matsuura Y. Molecular mechanism of translocation through nuclear pore complexes during nuclear protein import Febs Letters. 498: 145-149. PMID 11412846 DOI: 10.1016/S0014-5793(01)02489-9 |
0.04 |
|
2007 |
Richter S, Lindenstrauss U, Lücke C, Bayliss R, Brüser T. Functional Tat transport of unstructured, small, hydrophilic proteins. The Journal of Biological Chemistry. 282: 33257-64. PMID 17848553 DOI: 10.1074/jbc.M703303200 |
0.04 |
|
2020 |
Poon E, Liang T, Jamin Y, Walz S, Kwok C, Hakkert A, Barker K, Urban Z, Thway K, Zeid R, Hallsworth A, Box G, Ebus ME, Licciardello MP, Sbirkov Y, ... ... Bayliss R, et al. Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma. The Journal of Clinical Investigation. PMID 33016930 DOI: 10.1172/JCI134132 |
0.039 |
|
2017 |
Sabir SR, Yeoh S, Jackson G, Bayliss R. EML4-ALK Variants: Biological and Molecular Properties, and the Implications for Patients. Cancers. 9. PMID 28872581 DOI: 10.3390/cancers9090118 |
0.039 |
|
2024 |
Baschnagel AM, Flakus MJ, Wallat EM, Wuschner AE, Chappell RJ, Bayliss RA, Kimple RJ, Christensen GE, Reinhardt JM, Bassetti MF, Bayouth JE. A Phase 2 Randomized Clinical Trial Evaluating 4-Dimensional Computed Tomography Ventilation-Based Functional Lung Avoidance Radiation Therapy for Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 38387810 DOI: 10.1016/j.ijrobp.2024.02.019 |
0.039 |
|
2010 |
Bavetsias V, Large JM, Sun C, Bouloc N, Kosmopoulou M, Matteucci M, Wilsher NE, Martins V, Reynisson J, Atrash B, Faisal A, Urban F, Valenti M, De Haven Brandon A, Box G, ... ... Bayliss R, et al. Imidazo[4,5-b]pyridine derivatives as inhibitors of aurora kinases: Lead optimization studies toward the identification of an orally bioavailable preclinical development candidate Journal of Medicinal Chemistry. 53: 5213-5228. PMID 20565112 DOI: 10.1021/Jm100262J |
0.039 |
|
2013 |
Rowan FC, Richards M, Bibby RA, Thompson A, Bayliss R, Blagg J. Insights into Aurora-A kinase activation using unnatural amino acids incorporated by chemical modification. Acs Chemical Biology. 8: 2184-91. PMID 23924325 DOI: 10.1021/Cb400425T |
0.038 |
|
2012 |
Innocenti P, Cheung KM, Solanki S, Mas-Droux C, Rowan F, Yeoh S, Boxall K, Westlake M, Pickard L, Hardy T, Baxter JE, Aherne GW, Bayliss R, Fry AM, Hoelder S. Design of potent and selective hybrid inhibitors of the mitotic kinase Nek2: structure-activity relationship, structural biology, and cellular activity. Journal of Medicinal Chemistry. 55: 3228-41. PMID 22404346 DOI: 10.1021/Jm201683B |
0.038 |
|
2018 |
Ocasio CA, Warkentin AA, McIntyre PJ, Barkovich KJ, Vesely C, Spencer J, Shokat KM, Bayliss R. Type II kinase inhibitors targeting Cys-gatekeeper kinases display orthogonality with wild type and Ala/Gly-gatekeeper kinases. Acs Chemical Biology. PMID 30239186 DOI: 10.1021/Acschembio.8B00592 |
0.038 |
|
2010 |
Pandit JJ, Winter V, Bayliss R, Buckler KJ. Differential effects of halothane and isoflurane on carotid body glomus cell intracellular Ca2+ and background K+ channel responses to hypoxia. Advances in Experimental Medicine and Biology. 669: 205-8. PMID 20217350 DOI: 10.1007/978-1-4419-5692-7_41 |
0.038 |
|
1999 |
Bayliss R, Ribbeck K, Akin D, Kent HM, Feldherr CM, Görlich D, Stewart M. Interaction between NTF2 and xFxFG-containing nucleoporins is required to mediate nuclear import of RanGDP. Journal of Molecular Biology. 293: 579-93. PMID 10543952 DOI: 10.1006/Jmbi.1999.3166 |
0.037 |
|
2015 |
Magnuson WJ, Urban E, Bayliss RA, Harari PM. Impact of Node Negative Target Volume Delineation on Contralateral Parotid Gland Dose Sparing Using IMRT in Head and Neck Cancer. Technology in Cancer Research & Treatment. 14: 315-9. PMID 25782188 DOI: 10.1177/1533034614547456 |
0.037 |
|
2001 |
Quimby BB, Leung SW, Bayliss R, Harreman MT, Thirumala G, Stewart M, Corbett AH. Functional analysis of the hydrophobic patch on nuclear transport factor 2 involved in interactions with the nuclear pore in vivo. The Journal of Biological Chemistry. 276: 38820-9. PMID 11489893 DOI: 10.1074/Jbc.M105054200 |
0.037 |
|
2016 |
Mitcheson DF, Bottrill AR, Carr K, Coxon CR, Cano C, Golding BT, Griffin RJ, Fry AM, Doerig C, Bayliss R, Tobin AB. A new tool for the chemical genetic investigation of the Plasmodium falciparum Pfnek-2 NIMA-related kinase. Malaria Journal. 15: 535. PMID 27821169 DOI: 10.1186/s12936-016-1580-3 |
0.037 |
|
2016 |
Woo CG, Seo S, Kim SW, Jang SJ, Park KS, Song JY, Lee B, Richards MW, Bayliss R, Lee DH, Choi J. Differential protein stability and clinical responses of EML4-ALKfusion variants to various ALK inhibitors in advanced ALK-rearranged non-small cell lung cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28039177 DOI: 10.1093/annonc/mdw693 |
0.036 |
|
2006 |
Paschos A, Patey G, Sivanesan D, Gao C, Bayliss R, Waksman G, O'callaghan D, Baron C. Dimerization and interactions of Brucella suis VirB8 with VirB4 and VirB10 are required for its biological activity. Proceedings of the National Academy of Sciences of the United States of America. 103: 7252-7. PMID 16648257 DOI: 10.1073/Pnas.0600862103 |
0.035 |
|
2015 |
O'Regan L, Sampson J, Richards MW, Knebel A, Roth D, Hood FE, Straube A, Royle SJ, Bayliss R, Fry AM. Hsp72 is targeted to the mitotic spindle by Nek6 to promote K-fiber assembly and mitotic progression. The Journal of Cell Biology. 209: 349-58. PMID 25940345 DOI: 10.1083/Jcb.201409151 |
0.034 |
|
2016 |
Coxon CR, Wong C, Bayliss R, Boxall K, Carr KH, Fry AM, Hardcastle IR, Matheson CJ, Newell DR, Sivaprakasam M, Thomas H, Turner D, Yeoh S, Wang LZ, Griffin RJ, et al. Structure-guided design of purine-based probes for selective Nek2 inhibition. Oncotarget. PMID 27833088 DOI: 10.18632/oncotarget.13249 |
0.034 |
|
2023 |
Bayliss R, Sarnowska E, Yeoh S, Sampson J. ALKing the flames of lung cancer immunosensitivity. Molecular Oncology. 17: 2218-2220. PMID 37795653 DOI: 10.1002/1878-0261.13533 |
0.034 |
|
2020 |
Burr AR, Robins HI, Bayliss RA, Baschnagel AM, Welsh JS, Tomé WA, Howard SP. Outcomes From Whole-Brain Reirradiation Using Pulsed Reduced Dose Rate Radiation Therapy. Advances in Radiation Oncology. 5: 834-839. PMID 33083645 DOI: 10.1016/J.Adro.2020.06.021 |
0.033 |
|
2010 |
Bouloc N, Large JM, Kosmopoulou M, Sun C, Faisal A, Matteucci M, Reynisson J, Brown N, Atrash B, Blagg J, McDonald E, Linardopoulos S, Bayliss R, Bavetsias V. Structure-based design of imidazo[1,2-a]pyrazine derivatives as selective inhibitors of Aurora-A kinase in cells Bioorganic and Medicinal Chemistry Letters. 20: 5988-5993. PMID 20833547 DOI: 10.1016/J.Bmcl.2010.08.091 |
0.033 |
|
2018 |
Fearon D, Westwood IM, van Montfort RLM, Bayliss R, Jones K, Bavetsias V. Synthesis and profiling of a 3-aminopyridin-2-one-based kinase targeted fragment library: Identification of 3-amino-5-(pyridin-4-yl)pyridin-2(1H)-one scaffold for monopolar spindle 1 (MPS1) and Aurora kinases inhibition. Bioorganic & Medicinal Chemistry. PMID 29764757 DOI: 10.1016/J.Bmc.2018.04.033 |
0.033 |
|
2024 |
Bayliss RA, Bird R, Turner J, Chatterjee D, Lockey DJ. Haemodynamic response to pre-hospital emergency anaesthesia in trauma patients within an urban helicopter emergency medical service. European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society. PMID 38300282 DOI: 10.1007/s00068-024-02463-5 |
0.033 |
|
2000 |
Bayliss R, Kent HM, Corbett AH, Stewart M. Crystallization and initial X-ray diffraction characterization of complexes of FxFG nucleoporin repeats with nuclear transport factors Journal of Structural Biology. 131: 240-247. PMID 11052897 DOI: 10.1006/Jsbi.2000.4297 |
0.032 |
|
2007 |
Bayliss R, Harris R, Coutte L, Monier A, Fronzes R, Christie PJ, Driscoll PC, Waksman G. NMR structure of a complex between the VirB9/VirB7 interaction domains of the pKM101 type IV secretion system. Proceedings of the National Academy of Sciences of the United States of America. 104: 1673-8. PMID 17244707 DOI: 10.1073/Pnas.0609535104 |
0.032 |
|
1984 |
Bayliss R, Clarke C, Oakley CM, Somerville W, Whitfield AG, Young SE. The bowel, the genitourinary tract, and infective endocarditis. British Heart Journal. 51: 339-45. PMID 6696812 DOI: 10.1136/hrt.51.3.339 |
0.031 |
|
2009 |
Jakubowski SJ, Kerr JE, Garza I, Krishnamoorthy V, Bayliss R, Waksman G, Christie PJ. Agrobacterium VirB10 domain requirements for type IV secretion and T pilus biogenesis. Molecular Microbiology. 71: 779-94. PMID 19054325 DOI: 10.1111/J.1365-2958.2008.06565.X |
0.031 |
|
1984 |
Bayliss R, Clarke C, Oakley CM, Somerville W, Whitfield AG, Young SE. The microbiology and pathogenesis of infective endocarditis. British Heart Journal. 50: 513-9. PMID 6651993 DOI: 10.1136/hrt.50.6.513 |
0.029 |
|
1988 |
Bayliss R. Second opinions. British Medical Journal (Clinical Research Ed.). 296: 808-9. PMID 3130922 DOI: 10.1136/bmj.296.6625.808 |
0.029 |
|
2016 |
Flayhan A, Bergé C, Baïlo N, Doublet P, Bayliss R, Terradot L. Erratum: The structure of Legionella pneumophila LegK4 type four secretion system (T4SS) effector reveals a novel dimeric eukaryotic-like kinase. Scientific Reports. 6: 20746. PMID 26839176 DOI: 10.1038/srep20746 |
0.029 |
|
2018 |
Shimauchi T, Caucheteux S, Finsterbusch K, Turpin J, Blanchet F, Ladell K, Triantafilou K, Czubala M, Tatsuno K, Easter T, Ahmed Z, Bayliss R, Hakobyan S, Price DA, Tokura Y, et al. Dendritic cells promote the spread of human T-cell leukemia virus type-1 via bidirectional interactions with CD4 T-cells. The Journal of Investigative Dermatology. PMID 30048652 DOI: 10.1016/j.jid.2018.06.188 |
0.029 |
|
2020 |
Bayliss R, Wheeldon J, Caucheteux SM, Niessen CM, Piguet V. Identification of Host Trafficking Genes Required for HIV-1 Virological Synapse Formation in Dendritic Cells. Journal of Virology. 94. PMID 32075937 DOI: 10.1128/JVI.01597-19 |
0.029 |
|
2017 |
Büchel G, Carstensen A, Mak KY, Roeschert I, Leen E, Sumara O, Hofstetter J, Herold S, Kalb J, Baluapuri A, Poon E, Kwok C, Chesler L, Maric HM, Rickman DS, ... ... Bayliss R, et al. Association with Aurora-A Controls N-MYC-Dependent Promoter Escape and Pause Release of RNA Polymerase II during the Cell Cycle. Cell Reports. 21: 3483-3497. PMID 29262328 DOI: 10.1016/J.Celrep.2017.11.090 |
0.028 |
|
2015 |
Bavetsias V, Pérez-Fuertes Y, McIntyre PJ, Atrash B, Kosmopoulou M, O'Fee L, Burke R, Sun C, Faisal A, Bush K, Avery S, Henley A, Raynaud FI, Linardopoulos S, Bayliss R, et al. 7-(Pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine-based derivatives for kinase inhibition: Co-crystallisation studies with Aurora-A reveal distinct differences in the orientation of the pyrazole N1-substituent. Bioorganic & Medicinal Chemistry Letters. 25: 4203-9. PMID 26296477 DOI: 10.1016/J.Bmcl.2015.08.003 |
0.028 |
|
2016 |
Hall G, Cullen E, Sawmynaden K, Arnold J, Fox S, Cowan R, Muskett FW, Matthews D, Merritt A, Kettleborough C, Cruikshank W, Taylor D, Bayliss R, Carr MD. Structure of a potential therapeutic antibody bound to IL-16: mechanistic insights and new therapeutic opportunities. The Journal of Biological Chemistry. PMID 27231345 DOI: 10.1074/jbc.M115.709303 |
0.027 |
|
2014 |
Fry AM, Leaper MJ, Bayliss R. The primary cilium: guardian of organ development and homeostasis. Organogenesis. 10: 62-8. PMID 24743231 DOI: 10.4161/org.28910 |
0.027 |
|
2000 |
Bayliss R, Littlewood T, Stewart M. Structural basis for the interaction between FxFG nucleoporin repeats and importin-beta in nuclear trafficking. Cell. 102: 99-108. PMID 10929717 DOI: 10.1016/S0092-8674(00)00014-3 |
0.027 |
|
1980 |
Bayliss RA. The Round Table Club, Edinburgh. The Practitioner. 224: 438-40. PMID 7001424 |
0.026 |
|
2018 |
Witt JS, Musunuru HB, Bayliss RA, Howard SP. Large volume re-irradiation for recurrent meningioma with pulsed reduced dose rate radiotherapy. Journal of Neuro-Oncology. PMID 30392090 DOI: 10.1007/s11060-018-03011-z |
0.025 |
|
2011 |
Collins TP, Bayliss R, Churchill GC, Galione A, Terrar DA. NAADP influences excitation-contraction coupling by releasing calcium from lysosomes in atrial myocytes. Cell Calcium. 50: 449-58. PMID 21906808 DOI: 10.1016/j.ceca.2011.07.007 |
0.025 |
|
2003 |
Bayliss R. Axel Munthe's The story of San Michele revisited. Clinical Medicine (London, England). 3: 179-81. PMID 12737380 DOI: 10.7861/clinmedicine.3-2-179 |
0.025 |
|
2017 |
Chavali PL, Stojic L, Meredith LW, Joseph N, Nahorski MS, Sanford TJ, Sweeney TR, Krishna BA, Hosmillo M, Firth AE, Bayliss R, Marcelis CL, Lindsay S, Goodfellow I, Woods CG, et al. Neurodevelopmental protein Musashi 1 interacts with the Zika genome and promotes viral replication. Science (New York, N.Y.). PMID 28572454 DOI: 10.1126/science.aam9243 |
0.024 |
|
1981 |
Bayliss RA, Ellis CW. Neil Arnott, F.R.S., reformer, innovator and popularizer of science, 1788-1874. Notes and Records of the Royal Society of London. 36: 103-24. PMID 11610943 |
0.022 |
|
2015 |
Wojcieszynski AP, Rosenberg SR, Brower JV, Hullett CR, Geurts MW, Labby ZE, Hill PM, Bayliss RA, Paliwal B, Bayouth JE, Harari PM, Bassetti MF. Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26627702 DOI: 10.1016/J.Radonc.2015.10.024 |
0.022 |
|
2018 |
Labby ZE, Barraclough B, Bayliss RA, Besemer AE, Dunkerley DAP, Howard SP. Radiation treatment planning and delivery strategies for a pregnant brain tumor patient. Journal of Applied Clinical Medical Physics. PMID 30062720 DOI: 10.1002/acm2.12262 |
0.021 |
|
2015 |
Burgess SG, Bayliss R. The structure of C290A:C393A Aurora A provides structural insights into kinase regulation. Acta Crystallographica. Section F, Structural Biology Communications. 71: 315-9. PMID 25760707 DOI: 10.1107/S2053230X15002290 |
0.02 |
|
2012 |
Bavetsias V, Crumpler S, Sun C, Avery S, Atrash B, Faisal A, Moore AS, Kosmopoulou M, Brown N, Sheldrake PW, Bush K, Henley A, Box G, Valenti M, de Haven Brandon A, ... ... Bayliss R, et al. Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemia. Journal of Medicinal Chemistry. 55: 8721-34. PMID 23043539 DOI: 10.1021/Jm300952S |
0.017 |
|
2015 |
Gutiérrez-Caballero C, Burgess SG, Bayliss R, Royle SJ. TACC3-ch-TOG track the growing tips of microtubules independently of clathrin and Aurora-A phosphorylation. Biology Open. 4: 170-9. PMID 25596274 DOI: 10.1242/bio.201410843 |
0.016 |
|
2004 |
Bayliss R. The arrogance of youth. Lancet (London, England). 363: 1793. PMID 15172779 DOI: 10.1016/S0140-6736(04)16306-X |
0.015 |
|
1986 |
Bayliss R, Clarke C, Whitfield AG. The female life span. Journal of the Royal College of Physicians of London. 20: 290-3. PMID 3772851 |
0.014 |
|
1896 |
Bayliss RA. NOTE ON A CASE OF PLACENTA PRÆVIA The Lancet. 147: 98-99. |
0.011 |
|
1978 |
Mallya RK, Isaacs AJ, Bayliss R. Hashimoto's thyroiditis presenting as T3 toxicosis British Medical Journal. 2: 1535-1536. PMID 581560 |
0.01 |
|
1987 |
Bayliss R, Clarke C, Whitfield AG. Problems in comparative longevity. Journal of the Royal College of Physicians of London. 21: 134-9. PMID 3585833 |
0.01 |
|
2022 |
Caucheteux SM, Wheeldon J, Bayliss R, Piguet V. Macrophage Migration Inhibitory Factor restriction of HIV-1 trans-infection from Dendritic Cells to CD4+ T-cells via regulation of autophagy. The Journal of Investigative Dermatology. PMID 36257465 DOI: 10.1016/j.jid.2022.09.655 |
0.01 |
|
2011 |
Bayliss R. Miscellanea: A health hazard. British Medical Journal (Clinical Research Ed.). 285: 1824-5. PMID 20741954 DOI: 10.1136/bmj.285.6357.1824 |
0.01 |
|
2003 |
Bayliss R. A glass of water. Journal of the Royal Society of Medicine. 96: 148. PMID 12612120 DOI: 10.1177/014107680309600313 |
0.01 |
|
2002 |
Bayliss R. Sir John Franklin's last arctic expedition: a medical disaster. Journal of the Royal Society of Medicine. 95: 151-3. PMID 11872772 DOI: 10.1258/jrsm.95.3.151 |
0.01 |
|
1990 |
Howarth S, Clarke C, Bayliss R, Whitfield AG, Semmence J, Healy MJ. Mortality in elderly patients admitted for respite care. Bmj (Clinical Research Ed.). 300: 844-7. PMID 2186826 DOI: 10.1136/bmj.300.6728.844 |
0.01 |
|
1988 |
Whitfield AG, Bayliss R, Clarke C. Deaths in the first 20 years and problems of the sex ratio at birth. Journal of the Royal College of Physicians of London. 21: 270-4. PMID 3681787 |
0.01 |
|
1987 |
Baker RA, Bayliss RA. William John Ritchie Simpson (1855-1931): public health and tropical medicine. Medical History. 31: 450-65. PMID 3316879 DOI: 10.1017/S0025727300047293 |
0.01 |
|
1986 |
Bayliss R, Clarke C, Oakley CM, Somerville W, Whitfield AG, Young SE. Incidence, mortality and prevention of infective endocarditis. Journal of the Royal College of Physicians of London. 20: 15-20. PMID 3944771 |
0.01 |
|
1984 |
Bayliss R, Clarke C, Whitehead TP, Whitfield AGW. The management of hyperuricaemia Journal of the Royal College of Physicians of London. 18: 144-146. PMID 6726668 |
0.01 |
|
1980 |
Bayliss RA. Andrew Moir: an Aberdeen anatomist. Scottish Medical Journal. 25: 315-9. PMID 7010594 |
0.01 |
|
1980 |
Isaacs AJ, Leslie RDG, Gomez J, Bayliss R. The effect of weight gain on gonadotropins and prolactin in anorexia nervosa Acta Endocrinologica. 94: 145-150. PMID 6774545 |
0.01 |
|
1978 |
Leslie RDG, Isaacs AJ, Gomez J, Raggatt PR, Bayliss R. Hypothalamo-pituitary-thyroid function in anorexia nervosa: Influence of weight gain British Medical Journal. 2: 526-528. PMID 698555 DOI: 10.1136/bmj.2.6136.526 |
0.01 |
|
1978 |
Bayliss RA. Samuel Smiles--surgeon. The Practitioner. 220: 332-4. PMID 345260 |
0.01 |
|
1976 |
Bayliss RA. Flexner, smithells and home economics Journal of Educational Administration and History. 8: 9-18. DOI: 10.1080/0022062760080202 |
0.01 |
|
1974 |
Bayliss R. John Gray M'Kendrick, physiologist (1841-1926). Medical History. 17: 288-303. PMID 4595547 DOI: 10.1017/s0025727300018767 |
0.01 |
|
1972 |
Bayliss RA, Lockie GM, Taggart NR. A question of communication International Journal of Food Sciences and Nutrition. 26: 344-347. DOI: 10.3109/09637487209143831 |
0.01 |
|
1899 |
Bayliss RA. Rheumatoid arthritis in chronic disease of the middle ear Laryngoscope. 7: 269-273. |
0.01 |
|
1893 |
Bayliss RA. EXTENSIVE PEMPHIGUS IN ACUTE RHEUMATISM The Lancet. 142: 439. |
0.01 |
|
Hide low-probability matches. |